BRIEF—Merck inaugurates state-of-the-art pharma packaging center in Darmstadt

Merck KGaA, the German science and technology company, today inaugurated a new packaging center at its headquarters in Darmstadt, Germany.

The new 15,000 square meters facility will be dedicated to the packaging and shipping of Merck’s current portfolio of pharma medicines in more than 90 countries and help meet increasing patient needs for flagship medicines Glucophage (metformin), Concor (bisoprolol) and Euthyrox (bisoprolol) in the areas of diabetes, cardiovascular diseases and thyroid disorders respectively.

It will also provide capacity for potential future pharma products currently in clinical development such as evobrutinib in the area of neurology-immunology or tepotinib in the area of oncology.

The new pharma packaging center represents an investment of 63 million euros ($73 million) over the 2015-2018 period and is part of a wider 1 billion-euro investment up to 2020 transforming the Darmstadt site into contemporary global headquarters.